PCMI
AVNS

Paradigm Capital Management Inc’s Avanos Medical AVNS Stock Holding History

Paradigm Capital Management Inc’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,160
Closed -$263K – 162
2019
Q1 		$263K Buy
6,160
+460
+8% +$20.6K 0.02% 148
2018
Q4 		$255K Hold
5,700
– – 0.03% 147
2018
Q3 		$390K Buy
+5,700
New +$367K 0.03% 151

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Paradigm Capital Management Inc's AVNS Position: Q2 2019 in Review

Paradigm Capital Management Inc sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 6,160 shares — an estimated $263K sold.

Paradigm Capital Management Inc first reported a position in AVNS in Q3 2018 and held it in 3 quarters. The position peaked at $390K in Q3 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Paradigm Capital Management Inc reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Paradigm Capital Management Inc sold 6,160 Avanos Medical shares in Q2 2019, an estimated $263K.
  • Paradigm Capital Management Inc first reported a position in Avanos Medical in Q3 2018 and held it in 3 quarters.
  • Paradigm Capital Management Inc's Avanos Medical position peaked at $390K in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Paradigm Capital Management Inc's 13F filing for Q2 2019, filed 8 Aug 2019.